Better Monitoring of Cisplatin-Induced Ototoxicity Needed

More than half of patients treated with cisplatin develop hearing impairment, but there are few guidelines on the monitoring, prevention, and management of ototoxicity.
Medscape Medical News

source https://www.medscape.com/viewarticle/991347?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors